February 3, 2017
Allergan expects annual dividend rise
Allergan’s boss Brent Saunders said that the company plans to increase dividend on an annual basis over time.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
February 3, 2017
ESC: Air pollution impairs the function of blood vessels in the lungs
Dr Jean-Francois Argacha, a cardiologist at the University Hospital (UZ) Brussels, Belgium, said that this is the first study that reports an influence of air pollution on pulmonary vascular function and it represents major public health issue for people living in polluted urban areas where exercise could damage the lungs and potentially lead to decompensated heart failure.
February 3, 2017
DBV Technologies completes P II study of milk-induced EoE treatment
DBV Technologies has completed a Phase IIA investigator-initiated clinical trial of Viaskin Milk for the treatment of milk-induced Eosinophilic Esophagitis (EoE) in children ages 4-17 has been completed.
February 3, 2017
FDA approves Bristol-Myers’s Opdivo for urothelial bladder cancer
U.S. Food and Drug Administration (FDA) has approved Bristol-Myers’s Opdivo injection, for treatment of urothelial carcinoma (mUC).
February 2, 2017
Eli Lilly keeps Alimta patent in Japan for now, new challenges on the way
Japan IP High Court confirmed validity of Eli Lilly’s Alimta vitamin regimen patents, and has invalidated trials initiated by Sawai regarding Lilly’s vitamin regimen patents for Alimta.
February 2, 2017
MENA biologics industry first ever Biopharma Conference at CPhI Istanbul 2017
With the goal of developing Turkey as an R&D and technology hub, the Government has put place a number of measures to stimulate expansion of biotechnology and biopharmaceutical activities.
February 2, 2017
Pharmapack Europe 2017 Award Winners: Vial injector, pharma compliance pack, smart packaging and autoinjector for prefilled syringes named best innovations
UBM EMEA’s Pharmapack Europe 2017 has named the winners of the 2017 Pharmapack Awards on Wednesday, picking four innovations in the Exhibitor Innovation category, while two winners were chosen to get awards in the Health Product category.
February 2, 2017
NeuroVive to present hepatocellular carcinoma research results at EASL HCC Summit
NeuroVive Pharmaceutical, the mitochondrial medicine company, will present preclinical data from a new generation of sanglifehrin-based compounds with potent inhibitory…
February 2, 2017
Simens Healthcare palces first order from BioPorto
Danish provider of clinical diagnostic tests BioPorto, has finalized a distribution deal with Simens Healthcare for delivery of a NGAL test adapted for Siemens Healthcare BN II and BN ProSpec Systems.
February 2, 2017
Galapagos starts phase II of CF drug testing, opens IND with FDA and triggers $10M payment from AbbVie
Galapagos has started dosing of the first patient with cystic fibrosis (CF) Class III (F508del and a gating mutation like G551D)…